Association of a Proposed New Staging System for Folliculotropic Mycosis Fungoides With Prognostic Variables in a US Cohort

Authors:

Abstract
Folliculotropic mycosis fungoides (FMF) was recognized as a distinct entity and distinguished from conventional mycosis fungoides (CMF) by its clinicopathologic features and purportedly worse prognosis.1-8 Differing survival data for FMF have been reported. In 2002, the first retrospective cohort study of patients with FMF4 reported a poor prognosis when compared with stage-matched patch- or plaque-stage CMF, with 5- and 10-year disease-specific survival (DSS) rates of 68% and 26%, respectively, and 5- and 10-year overall survival rates of 64% and 14%, respectively. In 2008, a US study5 also reported poor survival, with 10- and 15-year overall survival rates of 82% and 41%, respectively. However, later non-US studies described better survival,9-14 including a few reporting overall survival as favorable as 94%11 to 100%.10,12 It has been hypothesized that such discrepancies partially stem from using different FMF definitions and therefore that studies have analyzed different cohorts of patients. In particular, it has been suggested that studies reporting a poorer prognosis included mostly patients with advanced-stage disease, whereas others demonstrating a good prognosis included mostly patients with early-stage disease. Therefore, a new FMF-specific staging system, which divides patients between early and advanced cutaneous stages, has been proposed.15 This system, currently lacking full validation, is considered potentially better associated with survival in FMF compared with the tumor-node-metastasis-blood (TNMB) system for CMF. Thus, we sought to test its utility in estimating survival in our institutional cohort of patients with FMF. In addition, although the implicit assumption behind using cutaneous stage as the parameter is that stage is best associated with survival, we wanted to test this assumption in our cohort by performing Cox proportional hazards regression modeling to examine multiple variables associated with overall survival and DSS in the entire cohort.

This publication has 18 references indexed in Scilit: